Thrombolytic application of reteplase and the change of pulmonary arterial pressure in pulmonary embolism. (12th October 2011)

• Record Type: Journal Article
• Authors: Liu, Zhaochuan; Liu, Zhaochuan; Wang, Junling
• Is Part Of: Heart. Volume 97(2011)Supplement 3
• Page Start: A188
• Page End: A189
• Publication Date: 2011-10-12
• Subjects: Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/heartjnl-2011-300867.552
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : Objective: To study the thrombolytic application of reteplase and the change of pulmonary arterial pressure in patients with the significant pulmonary embolism. Methods: Patients who were confirmed by 320 row helical CT whose pulmonary embolism was more than segmental. 20 mg diluted reteplase was given interval of 30 min 2 times by slow bolus. The changes of blood coagulation, clinical symptoms in patients were observed, as well as the pulmonary arterial pressure. Results: In 15 PE patients with male to female ratio of 4 (12/3), within 24 h after the reteplase thrombolysis, the patients with chest pain, dyspnoea relief were in 12 cases (80%); 2 h after thrombolysis, patients with cerebral haemorrhage was in 1 case (6%); 1 week after, the patients with the revascularisation prompted by pulmonary artery imaging were 12 (80%). The pulmonary artery pressure was observed by echocardiography in patients with pulmonary embolism, pulmonary arterial hypertension in patients before thrombolytic therapy were in 8 cases (53%), within 48 h after reteplase thrombolysis, the marked decline in patients with pulmonary hypertension, with a statistically significant difference (p<0.05). Conclusions: In patients with more than segmental pulmonary embolism by the 320-row spiral CT imaging, reteplase thrombolysis was safe and effective, and could relieve symptoms and pulmonary vascular recanalisation rate. In pulmonary embolism patients with pulmonary hypertension, the pulmonary vascular recanalisation by thrombolysis can reduce the pulmonary arterial pressure.